A Phase I/II Clinical Study of Immunotherapy for Advanced Colorectal Cancers Using CEA-Pulsed Dendritic Cells Mixed With Tetanus Toxoid and Subsequent IL-2 Treatment
Sponsor study identifier
interventional
37
1 country
1
Study Start
July 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
July 2005
Date type not reportedThis date has not been verified as actual or estimated.
The specific aims of this study are as follows:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 2005
Date type not reportedThis date has not been verified as actual or estimated.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 2005
Date type not reportedThis date has not been verified as actual or estimated.
July 2005
Date type not reportedThis date has not been verified as actual or estimated.
September 8, 2005
Actual (reported)September 12, 2005
Actual (reported)evaluate the clinical responses of vaccinated patients 6 weeks after the first injection
evaluate the safety of this treatment and the immune responses against CEA before and after the treatment 6 weeks after the first injection
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
National Taiwan University Hospital
Taipei, Taiwan
Liu KJ, Chao TY, Chang JY, Cheng AL, Ch'ang HJ, Kao WY, Wu YC, Yu WL, Chung TR, Whang-Peng J. A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment. J Biomed Sci. 2016 Aug 24;23(1):64. doi: 10.1186/s12929-016-0279-7.
Jacqueline Whang-Peng, M.D.
National Health Research Institutes, Taiwan
Hui-Ju Ch'ang, M.D.
National Health Research Institutes, Taiwan
Ann-Li Cheng, M.D.
National Taiwan University Hospital
Ko-Jiunn Liu, Ph.D.
National Health Research Institutes, Taiwan
First Submitted
September 8, 2005
First Posted
September 12, 2005
Study Start
July 2005
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
July 2005
Date type not reportedIRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure
Contact the study team to confirm eligibility.
This date has not been verified as actual or estimated.
Last Updated
September 12, 2005
Record last verified: 2005-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: